Evidence map›Paper›PMID 41936686›Full record

ArticleAnnals of surgical oncology2026

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

Tom I Bootsma, Dide den Hollander, Milou J P Reuvers, Ingrid M E Desar, Roger Wilson, Michiel A J van de Sande, Winan J van Houdt, Ingrid C M van der Geest, Bart H W B Schreuder, Suzanne E J Kaal and 3 more

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tom I BootsmaDepartment of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. t.bootsma@erasmusmc.nl.ORCID http://orcid.org/0000-0002-6603-0507
Dide den HollanderDepartment of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Milou J P ReuversDepartment of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Ingrid M E DesarDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Roger WilsonSarcoma Patient Advocacy Global Network, Wölfersheim, Germany.
Michiel A J van de SandeDepartment of Orthopaedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Winan J van HoudtDepartment of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Ingrid C M van der GeestDepartment of Orthopaedic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Bart H W B SchreuderDepartment of Orthopaedic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Suzanne E J KaalDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Johannes J BonenkampDepartment of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Winette T A van der GraafDepartment of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Olga HussonDepartment of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.

Funding

EORTC Quality of Life Group grant no. 003-2018EORTC Quality of Life Group QLG
6 · The paper itself

Abstract

backgroundPhysical functioning (PF) is significantly affected following amputation for extremity/pelvic sarcomas. Commonly used health-related quality of life (HRQoL) measures such as the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) (C30) and the Toronto Extremity Salvage Score (TESS) have not been validated in this population. This study examines the challenges of measuring PF in patients with extremity/pelvic sarcoma after amputation. It explores how these patients interpret the TESS and C30, particularly regarding prosthesis and assistive device use. PF is considered within the International Classification of Functioning, Disability and Health (ICF) framework. PATIENTS AND

methodsWe conducted semistructured interviews with 20 patients who had undergone amputation for extremity/pelvic sarcoma, recruited from three Dutch sarcoma centers. Interviews explored patients' experiences of PF using the C30 and TESS. Thematic analysis was conducted, with data organized into key themes and subthemes within the ICF framework.

resultsAmputation impacts five interrelated ICF domains: body functions and structures, activity and participation, and environmental factors. Within body functions and structures, patients reported challenges related to sensory functions and pain, movement functions, and genital and reproductive health. In the domain of activity and participation, limitations were noted in general tasks and demands, mobility, self-care, domestic life, and community, social, and civic life. Environmental factors such as products and technology and social support also played a role.

conclusionsA tailored measurement strategy is needed for patients with sarcoma post-amputation. Importantly, neither the C30 nor the TESS explicitly accounts for these contextual factors, which can lead to inconsistent or inaccurate scoring of physical functioning in this population.

Indexed as

Amputation, SurgicalDisability EvaluationInternational Classification of Functioning, Disability and HealthQuality of LifeSarcomaActivities of Daily LivingAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisSurveys and QuestionnairesAmputationEORTC QLQ-C30Extremity sarcomaHealth-related quality of lifePatient-reported outcomesPhysical functioningPRO developmentTESS

Identifiers

PMID41936686
PMCPMC13242479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.